PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23439564-3	2013	PHF, DP and GA could significantly suppress the expression of allergic inflammatory cytokine IL-33-upregulated intercellular adhesion molecule (ICAM)-1, and the release of chemokines CCL2, CCL5, CXCL8 and inflammatory cytokine IL-6 from KU812 cells (all p < 0.05).	Gallic Acid	12-14	interleukin 6	Homo sapiens	227-231	
23439564-4	2013	With the combined use of dexamethasone (0.01 mug/mL) and GA (10 mug/mL), the suppression of ICAM-1 expression and CCL5 and IL-6 release of IL-33-activated KU812 cells were significantly greater than the use of GA alone (all p < 0.05).	Gallic Acid	57-59	interleukin 6	Homo sapiens	123-127	
16322071-6	2006	Gallic acid decreased the phorbol 12-myristate 13-acetate plus calcium ionophore A23187-stimulated pro-inflammatory cytokine gene expression and production such as TNF-alpha and IL-6 in human mast cells.	Gallic Acid	0-11	interleukin 6	Homo sapiens	178-182	
21420233-6	2011	This results in combinatorial inhibition of NFkappaB activity by gallic acid, which results in potent inhibition of NFkappaB target genes involved in inflammation, metastasis, anti-apoptosis and angiogenesis, such as IL-6, IL-8, COX2, CXCR4, XIAP, bcl2, VEGF.	Gallic Acid	65-76	interleukin 6	Homo sapiens	217-221	
31817563-3	2019	We find that the pretreatment with non-cytotoxic concentrations (0.5-1 mug/ml of gallic acid equivalent) of LPE inhibits interleukin-6 (IL-6)-induced cell migration and invasiveness in MKN-28 and AGS cells, as analyzed by wound and matrigel assays.	Gallic Acid	81-92	interleukin 6	Homo sapiens	121-134	
31584241-6	2020	RESULTS: In vitro and ex vivo studies clearly demonstrated that diglucosyl gallic acid (active A) and the formulation complex inhibited pollution mediated MMP1 protein, CYP1A1 gene expression, and IL-6 protein secretion, while caprylic/capric triglyceride, diacetyl boldine (active B) had anti-melanogenic effect in in vitro primary melanocyte monoculture and 3D spheroid model.	Gallic Acid	64-86	interleukin 6	Homo sapiens	197-201	
31817563-3	2019	We find that the pretreatment with non-cytotoxic concentrations (0.5-1 mug/ml of gallic acid equivalent) of LPE inhibits interleukin-6 (IL-6)-induced cell migration and invasiveness in MKN-28 and AGS cells, as analyzed by wound and matrigel assays.	Gallic Acid	81-92	interleukin 6	Homo sapiens	136-140	
30544066-6	2019	Our results showed that administration of GA significantly increased the expressions of IL-4, and IL-10, while down-regulated IL-1, IL-6, IL-12, IL-17, IL-23, TGF-beta and TNF-alpha expressions compared with a model control group in vitro and in vivo.	Gallic Acid	42-44	interleukin 6	Homo sapiens	132-136	
27665471-0	2016	The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.	Gallic Acid	105-116	interleukin 6	Homo sapiens	17-21	
27665471-10	2016	The level of IL-6 and its gene expression decreased significantly in PC3 cells treated with GA.	Gallic Acid	92-94	interleukin 6	Homo sapiens	13-17	
27104513-8	2016	Gallic acid and chlorogenic acid could suppress the release of pro-inflammatory cytokine IL-6 and chemokine CCL7 and CXCL8, respectively, in IL-31- and IL-33-treated eosinophils-dermal fibroblasts co-culture; while berberine could suppress the release of IL-6, CXCL8, CCL2 and CCL7 in the eosinophil culture and eosinophils-dermal fibroblasts co-culture (all p < 0.05).	Gallic Acid	0-11	interleukin 6	Homo sapiens	89-93	
27104513-8	2016	Gallic acid and chlorogenic acid could suppress the release of pro-inflammatory cytokine IL-6 and chemokine CCL7 and CXCL8, respectively, in IL-31- and IL-33-treated eosinophils-dermal fibroblasts co-culture; while berberine could suppress the release of IL-6, CXCL8, CCL2 and CCL7 in the eosinophil culture and eosinophils-dermal fibroblasts co-culture (all p < 0.05).	Gallic Acid	0-11	interleukin 6	Homo sapiens	255-259